Immunogenicity of Ribosomal Vaccines Isolated from Group A, Type 14 Streptococcus pyogenes

A ribosomal preparation isolated from group A, type 14 Streptococcus pyogenes protected mice against a challenge of 1,000 mean lethal doses. Optimal immunization consisted of subcutaneous administration of 326 μg of protein with Freund incomplete adjuvant. Animals immunized with higher or lower anti...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Infect Immun
Päätekijät:	Schalla, W. O., Johnson, W.
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1975
Aiheet:	Immunology
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC415199/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/806521/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.11.6.1195-1202.1975
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!